✦ LIBER ✦

Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome

✍ Scribed by Ida Casorelli; Judith Offman; Luca Mele; Livio Pagano; Simona Sica; Mariarosaria D’Errico; Giuseppe Giannini; Giuseppe Leone; Margherita Bignami; Peter Karran

Book ID: 117798947
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 389 KB
Volume: 2
Category: Article
ISSN: 1568-7864
DOI: 10.1016/s1568-7864(03)00020-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mismatch repair defects among italian ca

Mismatch repair defects among italian cases of secondary acute leukemia and myelodysplastic syndrome

✍ I. Casorelli; J. Offman; L. Mele; L. Pagano; S. Sica; G. Leone; P. Karran; M. Bi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

The mechanism of mismatch repair and the

The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome

✍ MartÃn-LÃ³pez, Juana V.; Fishel, Richard 📂 Article 📅 2013 🏛 Springer Netherlands 🌐 English ⚖ 474 KB

Histone deacetylase inhibitors for the t

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia

✍ Quintás-Cardama, A; Santos, F P S; Garcia-Manero, G 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Differentiating agents in the treatment

Differentiating agents in the treatment of leukemia and myelodysplastic syndromes

✍ Laurent Degos 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 269 KB

New agents in the treatment of childhood

New agents in the treatment of childhood leukemias and myelodysplastic syndromes

✍ Seth J. Corey 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 281 KB

Low-dose cytosine-arabinoside in the tre

Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

✍ Weh, H. J. ;Zschaber, R. ;Hossfeld, D. K. 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 189 KB